| scholarly article | Q13442814 |
| P50 | author | James P. O'Callaghan | Q64408371 |
| P2093 | author name string | Gretchen L Snyder | |
| Qiang Zhang | |||
| Wei Yao | |||
| William J Welsh | |||
| Roger L Papke | |||
| Hongwen Zhu | |||
| Lawrence P Wennogle | |||
| Youyi Peng | |||
| John Tomesch | |||
| P2860 | cites work | Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia | Q24338876 |
| From ab initio quantum mechanics to molecular neurobiology: a cation-pi binding site in the nicotinic receptor | Q24647112 | ||
| Neuronal nicotinic receptors in the human brain | Q28141480 | ||
| Looking back on the discovery of alpha-bungarotoxin | Q28146141 | ||
| A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment | Q28324465 | ||
| Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells | Q28379148 | ||
| Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q28842973 | ||
| Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures | Q29619985 | ||
| Property distribution of drug-related chemical databases. | Q30855791 | ||
| Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors | Q31147815 | ||
| Conformational sampling of druglike molecules with MOE and catalyst: implications for pharmacophore modeling and virtual screening | Q33365646 | ||
| International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. | Q33650110 | ||
| 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner | Q34446347 | ||
| Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors | Q34484845 | ||
| Neuronal nicotinic receptors: a perspective on two decades of drug discovery research | Q34657532 | ||
| Nicotinic acetylcholine receptors as targets for antidepressants. | Q34761238 | ||
| Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands | Q35137379 | ||
| Nicotine and nicotinic receptor involvement in neuropsychiatric disorders | Q35644549 | ||
| Nicotinic receptors and schizophrenia | Q35841683 | ||
| Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations | Q36201558 | ||
| Strategies for compound selection | Q36393838 | ||
| Selective alpha7 nicotinic acetylcholine receptor ligands | Q36512768 | ||
| Selective inhibition of acetylcholine-evoked responses of alpha7 neuronal nicotinic acetylcholine receptors by novel tris- and tetrakis-azaaromatic quaternary ammonium antagonists | Q37314383 | ||
| alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma? | Q37555312 | ||
| Structure and function of neuronal nicotinic acetylcholine receptors | Q41330529 | ||
| PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor | Q44158787 | ||
| Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671. | Q45226870 | ||
| Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors | Q48203305 | ||
| The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents | Q48269550 | ||
| Modification of seizure activity by electrical stimulation. I. After-discharge threshold. | Q48793610 | ||
| [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study | Q71513186 | ||
| Nicotinic antagonists in the treatment of nerve agent intoxication | Q81455159 | ||
| P6195 | funding scheme | extramural research | Q124503498 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | manufacturing | Q187939 |
| neurological disorder | Q3339235 | ||
| P5008 | on focus list of Wikimedia project | Wikimedia–NIOSH collaboration | Q104416361 |
| P304 | page(s) | 4825-30 | |
| P577 | publication date | 2010-08-15 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P859 | sponsor | NIOSH Health Effects Laboratory Division | Q123344455 |
| P1476 | title | Discovery of novel alpha7 nicotinic receptor antagonists | |
| P478 | volume | 20 |
| Q35733853 | Design and Synthesis of Nicotinic Acetylcholine Receptor Antagonists and their Effect on Cognitive Impairment. |
| Q58778215 | Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor |
| Q90454303 | Methylpiperidinium Iodides as Novel Antagonists for α7 Nicotinic Acetylcholine Receptors |
| Q38126962 | Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors |
| Q28388268 | Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists |
Search more.